Lepu Scientech Medical Technology's (HKG:2291) net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.
Shares of the firm were down over 9% in Tuesday's late-morning trade.
Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.
Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.
The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.